Get started
Author

Gabriela Fernanda De Larrañaga

Observed names: G F de Larrañaga, G LARRANAGA, G Larrañaga, G de Larrañaga, G. DE LARRAÑAGA, G. De Larrañaga, G. F. Larrañaga, G. Larrañaga, G. de Larrañaga, G.F. de Larrañaga, GF De Larrañaga, Gabriela De Larrañaga, Gabriela F de Larra??aga, Gabriela F de Larrañaga, Gabriela F. de Larrañaga, Gabriela de Larrañaga, de Larrañaga G., de Larrañaga, Gabriela Fernanda
Institution: Hospital Muñiz
ORCID: 0000-0002-2527-7298
Observed ORCID: 0000-0002-2527-7298
OpenAlex ID: A5027645045
Neutrophil Extracellular Traps in Sepsis
2014 · Gabriela Camicia, Roberto Pozner, et al. · Shock · 166
Circulating levels of tissue factor and proinflammatory cytokines in patients with primary antiphospholipid syndrome or leprosy related antiphospholipid antibodies
2005 · R R Forastiero, M E Martinuzzo, et al. · Lupus · 90
Viral load and disease progression as responsible for endothelial activation and/or injury in human immunodeficiency virus-1-infected patients
2003 · Gabriela F de Larrañaga, Alejandro Petroni, et al. · Blood Coagulation & Fibrinolysis · 75
Different Types of Antiphospholipid Antibodies in AIDS
1999 · Gabriela F. de Larrañaga, Ricardo R. Forastiero, et al. · Thrombosis Research · 69
Sex, ethnicity, and slow acetylator profile are the major causes of hepatotoxicity induced by antituberculosis drugs
2012 · Julián G Chamorro, Jorge P Castagnino, et al. · Journal of Gastroenterology and Hepatology · 67
Pregnancy failure in patients with obstetric antiphospholipid syndrome with conventional treatment: the influence of a triple positive antibody profile
2017 · J O Latino, S Udry, et al. · Lupus · 60
High prevalence of antiphospholipid antibodies in leprosy: evaluation of antigen reactivity
2000 · G F de Larrañaga, R R Forastiero, et al. · Lupus · 59
Endothelial markers and HIV infection in the era of highly active antiretroviral treatment
2003 · Gabriela F de Larrañaga, Andrea R Bocassi, et al. · Thrombosis Research · 55
Relationship between hepatitis C virus (HCV) and insulin resistance, endothelial perturbation, and platelet activation in HIV–HCV–coinfected patients under highly active antiretroviral treatment
2006 · G. F. Larrañaga, S. D. A. Perés Wingeyer, et al. · European Journal of Clinical Microbiology & Infectious Diseases · 37
A focus on the roles of histones in health and diseases
2021 · Mauro Moiana, Federico Aranda, et al. · Clinical Biochemistry · 33
Heparin-coated circuit in coronary surgery*A clinical study
1996 · A SAENZ, G LARRANAGA, et al. · European Journal of Cardio-Thoracic Surgery · 25
Paternal factor V Leiden and recurrent pregnancy loss: a new concept behind fetal genetics?
2014 · S. Udry, F.M. Aranda, et al. · Journal of Thrombosis and Haemostasis · 24
Effect of gene–gene and gene–environment interactions associated with antituberculosis drug-induced hepatotoxicity
2017 · Julián G. Chamorro, Jorge P. Castagnino, et al. · Pharmacogenetics and Genomics · 22
Risk factors for early severe preeclampsia in obstetric antiphospholipid syndrome with conventional treatment. The impact of hydroxychloroquine
2020 · José Omar Latino, Sebastián Udry, et al. · Lupus · 19
Heparin-platelet Factor 4 Induced Antibodies in Patients with either Autoimmune or Alloimmune Antiphospholipid Antibodies
2002 · M. Martinuzzo, A. Bocassi, et al. · Thrombosis and Haemostasis · 18
Maternal carriers of the ANXA5 M2 haplotype are exposed to a greater risk for placenta-mediated pregnancy complications
2018 · Federico Aranda, Sebastián Udry, et al. · Journal of Assisted Reproduction and Genetics · 17
PDF
Biomarkers in sepsis at time zero: intensive care unit scores, plasma measurements and polymorphisms in Argentina
2011 · Silvia Daniela Amanda Perés Wingeyer, Eleonora Roxana Cunto, et al. · The Journal of Infection in Developing Countries · 17
PDF
Anti‐β2glycoprotein I antibodies from leprosy patients do not show thrombogenic effects in an in vivo animal model
2011 · R. FORASTIERO, M. MARTINUZZO, et al. · Journal of Thrombosis and Haemostasis · 16
False positive reactions in confirmatory tests for syphilis in presence of antiphospholipid antibodies: misdiagnosis with prognostic and social consequences
2006 · Gabriela de Larrañaga, Luis Trombetta, et al. · Dermatology Online Journal · 15
The distribution of allelic and genotypic frequencies of N-Acetyltransferase-2 variants in an Argentine population
2012 · Julián Gabriel Chamorro, Jorge P Castagnino, et al. · The Journal of Infection in Developing Countries · 14
PDF
Thrombophilia in Human Immunodeficiency Virus—Infected Patients with Osteonecrosis: Is There a Real Connection? The First Case-Control Study
2007 · Gabriela de Larrañaga, Edgardo Bottaro, et al. · Clinical and Applied Thrombosis/Hemostasis · 14
A high-risk laboratory profile of antiphospholipid antibodies and thrombosis is associated with a large number of extra-criteria manifestations in obstetric antiphospholipid syndrome
2019 · Sebastián Udry, José Omar Latino, et al. · Immunologic Research · 13
Markers of platelet, endothelial cell and blood coagulation activation in leprosy patients with antiphospholipid antibodies.
2002 · M E Martinuzzo, G F de Larrañaga, et al. · PubMed · 13
Clinical and therapeutic value of the adjusted Global Antiphospholipid Syndrome Score in primary obstetric antiphospholipid syndrome
2022 · Sebastián Udry, Stephanie Morales Peréz, et al. · Lupus · 12
Inherited thrombophilia and pregnancy loss. Study of an Argentinian cohort
2019 · Silvia Perés Wingeyer, Federico Aranda, et al. · Medicina Clínica (English Edition) · 12
Works count: 78
Citation count: 1,159
H-index: 17
I10-index: 32
Year
Topic
Type